Clinical Trial Update: Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating low-dose chemotherapy combined with immuno-targeted therapies for newly diagnosed adult Philadelphia chromosome-negative B-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | Status: RECRUITING